The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S,E)-N-(1-(3,5-Bis(trifluoromethyl)phenyl)ethyl)-3-(6-bromopyridin-2-yl)-2-cyanoacrylamide ID: ALA1923246
PubChem CID: 57396066
Max Phase: Preclinical
Molecular Formula: C19H12BrF6N3O
Molecular Weight: 492.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
Standard InChI: InChI=1S/C19H12BrF6N3O/c1-10(11-5-13(18(21,22)23)8-14(6-11)19(24,25)26)28-17(30)12(9-27)7-15-3-2-4-16(20)29-15/h2-8,10H,1H3,(H,28,30)/b12-7+/t10-/m0/s1
Standard InChI Key: OHQKJWNLDVIVTH-QVIVLVACSA-N
Molfile:
RDKit 2D
30 31 0 0 0 0 0 0 0 0999 V2000
-3.9973 -17.1791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9984 -18.0065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2836 -18.4194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5672 -18.0060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5700 -17.1755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2854 -16.7664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8571 -16.7603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1411 -17.1701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4282 -16.7549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1388 -17.9956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1357 -18.8206 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2878 -17.1647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4313 -15.9299 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0008 -16.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7168 -17.1593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7170 -17.9844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4322 -18.3941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1461 -17.9789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1403 -17.1496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4245 -16.7437 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7118 -16.7668 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
0.9976 -15.9245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4349 -19.2191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7218 -19.6340 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1507 -19.6293 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.4292 -20.0417 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.8517 -16.7319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5692 -17.1392 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.8457 -15.9070 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.5625 -16.3125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14 15 1 0
3 4 2 0
15 16 2 0
7 8 2 0
16 17 1 0
17 18 2 0
8 9 1 0
18 19 1 0
4 5 1 0
19 20 2 0
20 15 1 0
2 3 1 0
1 21 1 0
10 11 3 0
14 22 1 1
8 10 1 0
17 23 1 0
5 6 2 0
23 24 1 0
9 12 1 0
23 25 1 0
6 1 1 0
23 26 1 0
9 13 2 0
19 27 1 0
1 2 2 0
27 28 1 0
12 14 1 0
27 29 1 0
5 7 1 0
27 30 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 492.22Molecular Weight (Monoisotopic): 491.0068AlogP: 5.67#Rotatable Bonds: 4Polar Surface Area: 65.78Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.98CX Basic pKa: 0.42CX LogP: 5.25CX LogD: 5.25Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.26Np Likeness Score: -1.37
References 1. Peng Z, Pal A, Han D, Wang S, Maxwell D, Levitzki A, Talpaz M, Donato NJ, Bornmann W.. (2011) Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myeloma., 19 (23): [PMID:22036213 ] [10.1016/j.bmc.2011.09.057 ]